Clinical Trials on AKI in Mexico

Total 5 results

Instituto Nacional de Ciencias Medicas y Nutricion...

Unknown

Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19 (oXAKI-COV)

Covid19 | AKI

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...
Olynka Vega Vega; Noemi del Toro Cisneros; Miguel Ángel Martínez Rojas

Recruiting

Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study (DAKI-CKD)

Biomarkers | CKD | AKI - Acute Kidney Injury | Transition to CKD

Mexico
Instituto Nacional de Enfermedades Respiratorias

Unknown

Renal Biomarkers in AKI and COVID-19

Coronavirus Infection | Covid19 | AKI | SARS (Severe Acute Respiratory Syndrome)

Mexico
Sanofi

Terminated

Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction (INTENSIVE)

AMI

Canada, Brazil, United States, Argentina, Mexico
Novo Nordisk A/S
Duke Clinical Research Institute

Not yet recruiting

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack (ARTEMIS)

Cardiovascular Risk | Acute Myocardial Infarction (AMI)

Canada, China, United States, Germany, Spain, Korea, Republic of, Netherlands, Australia, Italy, Denmark, India, United Kingdom, Argentina, Turkey, Mexico, Malaysia, Czechia, Poland, Brazil, France, Japan, Bulgaria, Greece, Israel

3

Subscribe